Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 4075-4085, August 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steen, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steen, R. G.

Response of Solid Tumors to Chemotherapy Monitored by in Vivo 31P Nuclear Magnetic Resonance Spectroscopy: A Review1

R. Grant Steen

Department of Radiology RC-05, University of Washington School of Medicine, Seattle, Washington 98195

In vivo 31P nuclear magnetic resonance (MR) spectroscopy has shown great promise as a tool for cancer research and the clinical management of solid tumors. It is now possible in some cases to integrate MR spectroscopy with routine MR imaging of the cancer patient, so that tissue identified as tumor on an MR image can be examined biochemically and monitored following treatment. Alterations have been observed in the phosphorus MR spectra of patient tumors after treatment, but the causes and consequences of these alterations are poorly understood. Here we review data obtained from experimental animal tumor models treated with chemotherapy in order to gain insight into the biological events reflected in MR spectroscopic changes, and to determine what information the spectra provide about the success or failure of therapeutic interventions. An attempt is made to relate these experimental findings to the cancer clinic and to analyze the contributions of MR spectroscopy to the understanding of tumor biology.

1 This work was supported in part by American Cancer Society Institutional Research Grant IN-26-31 and Biomedical Research Support Grant RR05432.

Received 1/16/89. Revised 4/ 4/89. Accepted 4/17/89.




This article has been cited by other articles:


Home page
Cancer Res.Home page
U. Duvvuri, H. Poptani, M. Feldman, L. Nadal-Desbarats, M. S. Gee, W. M. F. Lee, R. Reddy, J. S. Leigh, and J. D. Glickson
Quantitative T1{rho} Magnetic Resonance Imaging of RIF-1 Tumors in Vivo: Detection of Early Response to Cyclophosphamide Therapy
Cancer Res., November 1, 2001; 61(21): 7747 - 7753.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. M. Winter, H. Poptani, and N. Bansal
Effects of Chemotherapy by 1,3-Bis(2-chloroethyl)-1-nitrosourea on Single-Quantum- and Triple-Quantum-filtered 23Na and 31P Nuclear Magnetic Resonance of the Subcutaneously Implanted 9L Glioma
Cancer Res., March 1, 2001; 61(5): 2002 - 2007.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.